279 related articles for article (PubMed ID: 32771797)
1. Potential treatment methods targeting 2019-nCoV infection.
Zheng L; Zhang L; Huang J; Nandakumar KS; Liu S; Cheng K
Eur J Med Chem; 2020 Nov; 205():112687. PubMed ID: 32771797
[TBL] [Abstract][Full Text] [Related]
2. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
3. A global treatments for coronaviruses including COVID-19.
Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
[TBL] [Abstract][Full Text] [Related]
4. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
[TBL] [Abstract][Full Text] [Related]
5. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
6. [Potential antiviral therapeutics for 2019 Novel Coronavirus].
Li H; Wang YM; Xu JY; Cao B
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):170-172. PubMed ID: 32164080
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
8. Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
Gupta SP
Curr Top Med Chem; 2020; 20(26):2362-2378. PubMed ID: 32962613
[TBL] [Abstract][Full Text] [Related]
9. Psychopharmacology of COVID-19.
Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
[TBL] [Abstract][Full Text] [Related]
10. An update on novel COVID-19 pandemic: a battle between humans and virus.
Prajapati S; Sharma M; Kumar A; Gupta P; Narasimha Kumar GV
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5819-5829. PubMed ID: 32495921
[TBL] [Abstract][Full Text] [Related]
11. Research Progress of Drug Treatment in Novel Coronavirus Pneumonia.
Yan J; Liu A; Huang J; Wu J; Fan H
AAPS PharmSciTech; 2020 May; 21(4):130. PubMed ID: 32405780
[TBL] [Abstract][Full Text] [Related]
12. [Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP].
Ma J; Huo XQ; Chen X; Zhu WX; Yao MC; Qiao YJ; Zhang YL
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1219-1224. PubMed ID: 32281328
[TBL] [Abstract][Full Text] [Related]
13. [Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].
Niu M; Wang RL; Wang ZX; Zhang P; Bai ZF; Jing J; Guo YM; Zhao X; Zhan XY; Zhang ZT; Song XA; Qin EQ; Wang JB; Xiao XH
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1213-1218. PubMed ID: 32281327
[TBL] [Abstract][Full Text] [Related]
14. [Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].
Zhang YS; Cong WH; Zhang JJ; Guo FF; Li HM
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(6):1263-1271. PubMed ID: 32281335
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
Costanzo M; De Giglio MAR; Roviello GN
Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment.
Wang Z; Chen X; Lu Y; Chen F; Zhang W
Biosci Trends; 2020 Mar; 14(1):64-68. PubMed ID: 32037389
[TBL] [Abstract][Full Text] [Related]
17. Recent advances of therapeutic targets and potential drugs of COVID-19.
Zhang W; Zhang P; Wang G; Cheng W; Chen J; Zhang X
Pharmazie; 2020 May; 75(5):161-163. PubMed ID: 32393419
[TBL] [Abstract][Full Text] [Related]
18. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
19. Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19.
Zhu Z; Lu Z; Xu T; Chen C; Yang G; Zha T; Lu J; Xue Y
J Infect; 2020 Jul; 81(1):e21-e23. PubMed ID: 32283143
[TBL] [Abstract][Full Text] [Related]
20. The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.
Zhang K; Tian M; Zeng Y; Wang L; Luo S; Xia W; Zhang X; Zha Y
Complement Ther Med; 2020 Aug; 52():102473. PubMed ID: 32951723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
